Intravenous vitamin C in the supportive care of cancer patients: a review and rational approach

  • E. Klimant Salish Cancer Center
  • H. Wright Naturopathic Specialists http://orcid.org/0000-0003-3418-0487
  • D. Rubin Naturopathic Specialists
  • D. Seely Ottawa Integrative Cancer Centre
  • M. Markman Cancer Treatment Centers of America
Keywords: Vitamin C deficiency, intravenous vitamin C, ascorbate, supportive care, quality of life

Abstract

This article reviews intravenous vitamin C (IV C) in cancer care and offers a rational approach to enable medical oncologists and integrative practitioners to safely provide IV C combined with oral vitamin C to patients. The use of IV C is a safe supportive intervention to decrease inflammation in the patient and to improve symptoms related to antioxidant deficiency, disease processes, and side effects of standard cancer treatments. A proposed rationale, together with relevant clinical safety considerations for the application of IV C in oncologic supportive care, is provided.

Author Biographies

D. Seely, Ottawa Integrative Cancer Centre
Department of  Research and ClinicalEpidemiology
M. Markman, Cancer Treatment Centers of America
Department of Medical Oncology
Published
2018-04-30
How to Cite
Klimant, E., Wright, H., Rubin, D., Seely, D., & Markman, M. (2018). Intravenous vitamin C in the supportive care of cancer patients: a review and rational approach. Current Oncology, 25(2), 139-148. https://doi.org/10.3747/co.25.3790
Section
Review Article